Myocardial amyloidosis refers to amyloidosis cardiomyopathy, the cure rate of this disease is relatively low in clinical practice, or even incurable, if the patient’s physical quality is good, timely therapeutic interventions can effectively alleviate the symptoms, improve the quality of life, and prolong life.
1. Myocardial amyloidosis belongs to a class of myocardial dysfunction diseases, which can be divided into primary and secondary. Primary myocardial amyloidosis is mostly related to genetic factors, while secondary myocardial amyloidosis is mostly caused by rheumatoid arthritis, multiple myeloma and other disease factors.
2. The main symptom of the disease is cardiac insufficiency, accompanied by peripheral edema, palpitation, hypotension and other manifestations. At present, there is no special method to cure this kind of disease completely, and it needs to be treated and improved according to its own specific causes, and if necessary, it can be prolonged by liver transplantation.
Therefore, myocardial amyloidosis belongs to a more serious category of diseases, most patients generally have a poor prognosis, and it is recommended that patients actively cooperate with doctors for treatment, which will help prolong life.